Published in Virus Weekly, May 23rd, 2006
"Hepatic steatosis is common in patients with CHC and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC," wrote P. Perumalswami and colleagues, U.S. National Institute of Diabetes & Digestive & Kidney Diseases.
"The computerized pathology database at the National Institutes of Health Clinical Center was searched for patients with CHC who had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly